PharmaBoardroom

Marc Boutin – CEO, National Health Council, USA

Marc Boutin, JD, CEO of the National Health Council (NHC),* introduces the organization and its mission to provide a united voice for the 160 million…

Novartis: CAR-T’s Journey to Market in Europe

Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene…

Emanuele Ostuni – Head of Europe, Cell & Gene Therapy,…

Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the introduction of the company’s CAR-T…

GSK & Sanofi’s Unprecedented COVID-19 Vaccine…

The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are working together to develop a…

Belgium Takes Measures To Avoid Medicine Shortages During The…

On 8 April 2020, the Belgian federal agency for medicines and health products (‘FAMHP’) adopted a consolidated version of its decision (the…

Mouloud Boukhachab – Head of Africa Middle-East &…

Pierre Fabre’s recently appointed head for Africa, the Middle East and Turkey, Mouloud Boukhachab, outlines his career trajectory, having worked and…

Robert Matsuk – President, Glenmark North America

Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US - including a manufacturing facility…

Cell & Gene Therapy Manufacturing: Critical Challenges,…

Deloitte's Omkar Kawalekar, Hussain Mooraj, and Amit Agarwal examine the evolution and future of cell and gene therapy manufacturing and the areas in…

Brazil Pharma News Roundup April 2020

Below we highlight recent news in Brazilian pharma, including the impact of coronavirus as well as legal and regulatory updates. Proposal…

Management in the Age of Confinement

With the global coronavirus pandemic still ongoing and teleworking having become the new normal, pharma executives from across the world are giving us…

Biocon’s Recipe for Success in the Competitive US Generics…

Indian firm Biocon has seen great success in the US in recent years, with two biosimilar launches and a range of generic medicines now available on…

Why Technology Is Key To Surviving COVID-19

Sophia Ononye-Onyia outlines the key failings in the USA’s response to the coronavirus outbreak and why greater numbers of inter-industry…

Tagged with US